The FDA approved ustekinumab-aekn (Selarsdi) injection as an interchangeable biosimilar to Stelara for the treatment of Crohn ...

Distinct trends were seen in etiology-based mortality with chronic liver disease (CLD) before, during, and after the COVID-19 ...

Discover a recent study presented at EASL 2025 that explored the impact of opt-out testing for blood-borne viruses in ...

A nurse whose father died after being given infected blood has said he would have been “disgusted” at the way bereaved ...

Liver disease patients are falling through the cracks and not getting the treatment they need. Support from people with lived experience of disease could bridge the gap.

Discover an awarding winning abstract from EASL 2025 that has called for more person-centred hepatitis screening. Learn more.

As of 2022, an estimated 50 million people globally were infected with chronic hepatitis C virus (HCV), with an estimated 1 ...

Prince Edward Island has not met its target of eliminating hepatitis C in the province by 2025, but it's still ahead of the ...

Roche is rolling out a new diagnostic test to help assess hidden liver fibrosis in patients showing signs of metabolic ...

People given infected blood and blood products in one of the worst treatment disasters in NHS history have said they will “have justice” as hearings reopened into the scandal.

"The difference between living or dying can rest on whether or not the doctor knows about a particular condition." ...

White patients had an increased burden of advanced liver fibrosis vs Black patients, despite comparable levels of inflammation.